A/Prof Mehrdad Nikfarjam
Exploring the role of cannabinoids in the treatment of pancreatic cancer

MD, PhD, FRACS

Austin health, University of Melbourne

“The role of cannabinoids in the treatment of pancreatic cancer”

Background:  Advanced and minimally invasive liver, pancreatic and biliary surgeon with a focus on pancreatic cancer research.  Laboratory head of pancreatic cancer biology group. Clinical research: Advanced and minimally invasive pancreatic resection techniques.  Borderline resectable pancreatic cancers. Neoadjuvant and adjuvant chemotherapy trials.  Brachytherapy for treatment of pancreatic cancer. Enhanced post -operative recovery techniques.  Fluid sparing therapies in pancreatic surgery. Familial pancreatic cancer screening.

Basic Research: Mouse models of pancreatic cancer. K-ras targeted therapies. Role of P-21 Kinase in the development and progression of pancreatic cancer.  Novel therapies for the treatment of pancreatic cancer including use of Cannabis

Contribution to the field of research: I have over 150 peer-reviewed publications. I have written one book and have contributed 4 book chapters in leading surgical texts. I have publications in the highest ranked surgical journals that include Annals of Surgery, British Journal of Surgery, World Journal of Surgery and Annals of Surgical Oncology. I have co-authored five publications in Nature and two in Cancer Letters. I have had 40+ international presentations and 2000+ listed citations relating to my published work. I am a member of Victorian Integrated Cancer Services, Cancer Council and Victorian State Government committees developing guidelines to improve patient outcomes with pancreatic cancer.

lpbsurgery.com